Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
- 8-K - RE/MAX Holdings, Inc. (0001581091) (Filer)
RE/MAX Holdings, Inc. filed a Form 8-K with the SEC on August 6, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001104659-26-091642, 304 KB).
- 8-K - Commerce.com, Inc. (0001626450) (Filer)
Commerce.com, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - OPEN TEXT CORP (0001002638) (Filer)
Open Text Corp filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02), other events (Item 8.01), and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Zoetis Inc. (0001555280) (Filer)
Zoetis Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and related exhibits (Item 9.01).
- 8-K - Cullinan Therapeutics, Inc. (0001789972) (Filer)
Cullinan Therapeutics filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - Vistance Networks, Inc. (0001517228) (Filer)
Vistance Networks filed a Form 8-K reporting departures and appointments of officers and directors, related compensatory arrangements, other events, and accompanying financial statements and exhibits.
- 8-K - Smith Douglas Homes Corp. (0001982518) (Filer)
Smith Douglas Homes Corp. filed a Form 8-K on August 6, 2026, including Item 2.02 detailing its results of operations and financial condition, and Item 9.01 providing its financial statements and related exhibits.
- 8-K - Shift4 Payments, Inc. (0001794669) (Filer)
Shift4 Payments, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - Core Natural Resources, Inc. (0001710366) (Filer)
Core Natural Resources, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - BENTLEY SYSTEMS INC (0001031308) (Filer)
Bentley Systems Inc. filed a Form 8-K on August 6, 2026, disclosing its results of operations and financial condition and attaching its financial statements and related exhibits.
- 8-K - Resolute Holdings Management, Inc. (0002039497) (Filer)
Resolute Holdings Management, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer)
Iovance Biotherapeutics filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition (Item 2.02) and providing financial statements and exhibits (Item 9.01).
- 8-K - Tecnoglass Holdings Inc. (0001534675) (Filer)
Tecnoglass Holdings Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and exhibits (Item 9.01).
- 8-K - BlackSky Technology Inc. (0001753539) (Filer)
BlackSky Technology Inc. filed a Form 8-K on August 6, 2026 (Accession No. 0001753539-26-000118), reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Vital Farms, Inc. (0001579733) (Filer)
Vital Farms, Inc. filed a Form 8-K reporting entry into and termination of material definitive agreements, disclosed its results of operations and financial condition, created a direct financial obligation/off-balance-sheet arrangement, and provided related financial statements and exhibits.
- 8-K - Viridian Therapeutics, Inc.\DE (0001590750) (Filer)
Viridian Therapeutics, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - LIGAND PHARMACEUTICALS INC (0000886163) (Filer)
Ligand Pharmaceuticals Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Opus Genetics, Inc. (0001228627) (Filer)
Opus Genetics, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 covering its results of operations and financial condition and Item 9.01 containing its financial statements and exhibits.
- 8-K - Korro Bio, Inc. (0001703647) (Filer)
Korro Bio, Inc. filed a Form 8-K reporting a material definitive agreement, its results of operations and financial condition, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - Warner Bros. Discovery, Inc. (0001437107) (Filer)
Warner Bros. Discovery, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 (results of operations and financial condition), Item 7.01 (Regulation FD disclosure), and Item 9.01 (financial statements and exhibits).
- 8-K - Monte Rosa Therapeutics, Inc. (0001826457) (Filer)
Monte Rosa Therapeutics, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 results of operations and financial condition and Item 9.01 financial statements and exhibits.
- 8-K - Evolent Health, Inc. (0001628908) (Filer)
Evolent Health, Inc. filed a Form 8-K on August 6, 2026 (Accession No. 0001628908-26-000084) containing Item 2.02 on results of operations and financial condition and Item 9.01 with its financial statements and exhibits.
- 8-K - Cartesian Therapeutics, Inc. (0001453687) (Filer)
Cartesian Therapeutics, Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - GPGI, Inc. (0001823144) (Filer)
GPGI, Inc. submitted a Form 8-K on August 6, 2026, reporting results of operations and financial condition, other events, and accompanying financial statements and exhibits, under accession number 0001628280-26-053821.
- 8-K - Unity Software Inc. (0001810806) (Filer)
Unity Software Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations, financial condition, and accompanying financial statements and exhibits.
- 8-K - NEXSTAR MEDIA GROUP, INC. (0001142417) (Filer)
Nexstar Media Group, Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 covering results of operations and financial condition, and Item 9.01 containing its financial statements and related exhibits.
- Green notice 2026/02
The Bank of England issued Green notice 2026/02, indicating that significant proposals for its reporting may be finalized and, if implemented, will be included in a statistical notice.
- 8-K - FS KKR Capital Corp (0001422183) (Filer)
FS KKR Capital Corp filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching its financial statements and related exhibits.
- 8-K - NexPoint Real Estate Finance, Inc. (0001786248) (Filer)
NexPoint Real Estate Finance, Inc. filed a Form 8-K on August 6, 2026, reporting Item 2.02 results of operations and financial condition and Item 9.01 financial statements and exhibits.
- 8-K - SOMNIGROUP INTERNATIONAL INC. (0001206264) (Filer)
SomniGroup International Inc. filed a Form 8-K on August 6, 2026 (Accession No. 0001206264-26-000099, 983 KB), reporting Item 2.02 results of operations and financial condition, Item 8.01 other events, and Item 9.01 financial statements and exhibits.